Stage IV Melanoma Active Not Recruiting Phase 2 Trials for Nivolumab (DB09035)

IndicationStatusPhase
DBCOND0028660 (Stage IV Melanoma)Active Not Recruiting2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT02054520Immunotherapy Study for Patients With Stage IV MelanomaTreatment